CARDIOPROTECTIVE MECHANISMS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ISCHEMIC HEART DISEASE

Авторы

  • Mekhribon Khayrilloeva Автор
  • Nematulla Bobokambarov Автор
  • Buron Lapasov Автор

Ключевые слова:

To analyze the pharmacological mechanisms of cardioprotective action of empagliflozin in patients with T2DM and IHD

Аннотация

Type 2 diabetes mellitus (T2DM) significantly increases the risk of ischemic heart disease (IHD). Traditional hypoglycemic therapy often fails to reduce cardiovascular risk, which necessitates the use of drugs with proven cardioprotective effects

Загрузки

Опубликован

2026-06-04

Выпуск

2026: INDICATORS OF LATENT COURSE OF HIV INFECTION AMONG YOUTH AND EPIDEMIOLOGICAL FACTORS AFFECTING EARLY DETECTION

Раздел

Articles